Category:

A coalition of national and local pharmacy organizations is praising the Department of Health and Human Services’ decision to allow licensed pharmacists to order and administer COVID-19 tests during the new coronavirus disease pandemic...“The accessibility and distribution of retail and independent community-based pharmacies make pharmacists the first point of contact with a healthcare professional for many Americans,” said HHS Assistant Secretary for Health Brett P. Giroir, MD...“This will further expand testing for Americans, particularly our healthcare workers and first responders who are working around the clock to provide care, compassion and safety to others.”...READ MORE

Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding (APC). As of January 1, 2020, the new name has become official...The APC is an advocate on a number of issues related to patient access to compounded medications, including: encouraging national academies and chapters to seek input from prescribers, and dispensers of compounded bioidentical hormone replacement therapy; appealing beyond-use date restrictions in the new USP <795> and <797> chapters; and proposing a “middle way” to the FDA on a memorandum of understanding regarding state level regulation of patient-specific compounded medications...READ MORE

...Endo International...has prevailed in its two-front fight with the FDA and bulk compounders. The resolution has ended competition for its vessel constrictor Vasostrict...The drugmaker...has dropped its litigation against the FDA...the FDA amended its draft guidelines to stop compounders from making vasopressin...While the ruling is specific to vasopressin, it is believed to have precedent for other drugmakers whose drugs are targeted by large-scale compounders for generic competition...READ MORE

The deaths of 64 people and sickening of nearly 800 due to criminal negligence by employees of the New England Compounding Center in 2012 marked a profound failure of state and federal regulatory enforcement…led to…the Drug Quality and Security Act of 2013 provisions to create a more robust regulatory framework for compounding pharmacies…The legislation instructed the FDA to create regulations…that would assure patient safety while permitting local compounders to continue to meet patient needs by providing customized compounded medications using FDA-approved substances…But the FDA has overreached in implementing the provisions, all but halting common compounding practices that have been safely performed for years and on which patients with legitimate needs for compounded medications rely. Not only that, but the FDA has done so by circumventing the federal Administrative Procedure Act, issuing “guidance documents” to implement policies rather than following the statutory rule-making process that requires stakeholder input regarding proposed regulations…READ MORE

Pharmacists remain at the top of the Gallup’s annual survey of professionals that rank the highest in “honesty and ethics”...For the 18th year in a row, nurses ranked as the most trusted professionals, as 85% of Americans say their honesty and ethical standards are "very high" or “high”. Engineers placed second at 66%, followed by medical doctors (65%), and pharmacists (64%)...“Medical professions in general rate highly in Americans' assessments of honesty and ethics, with at least 6 in 10 US adults saying medical doctors, pharmacists, and dentists have high levels of these virtues,”...READ MORE

Ongoing threats to the safety of intravenous (IV) drug delivery include drug shortages and lack of IV product standardization, according to an expert panel...The panel of health care providers developed recommendations...The findings...were published in the American Journal of Health-System Pharmacy.

The panel’s findings include:

1. The panel believes in the overall superiority of manufacturer ready-to-use products, and says they are the safest IV drug delivery systems, followed by outsourced, ready-to-use, pharmacy compounded, point-of-care activated, and nonpharmacy compounded at point of care.
2. Drug shortages and lack of standardization are the 2 most significant threats to IV drug safety.
3. Variations in IV medication concentrations during transitions of care within the same institution or between different facilities can increase the likelihood of a medication error, leading the panel to identify lack of standardization as a major threat to safety.
4. Manufacturer-prepared products are the safest IV drug delivery system, and manufacturer-prepared, ready-to-administer products are preferred for patient use whenever possible...
5. Specialized education, training, certification, and competency with regard to compounding of sterile preparations should be required for pharmacists, pharmacy technicians, and other involved health care providers...
6. A legislative and regulatory framework that supports and encourages IV medication safety in all settings (such as physician offices) should be developed…READ MORE

New technology, enabling consumers to read packaging labels written in any language, will become the norm for the pharmaceutical industry within 12 months...A prototype video, shown on the Third Aurora website, demonstrates the solution with a prototype package being translated from English to Spanish, German, Russian, and Japanese...Behind the scenes, two technologies are at work. According to Chaffey, “Artificial intelligence reads and interprets the content and augmented reality projects the new text back onto the label.”...READ MORE

Quality, speed, and price has been referred to as the "Unattainable Triangle". Fast, good, cheap—pick 2. Every business faces this question every time the doors are open for business. You can’t possibly have all 3. When you try to improve 1 side of the triangle, the other 2 sides will be impacted...think about our individual struggle with the triangle. How many of us are in low quality, high stressed jobs because of our “price” (salary)? In a fulfilling pharmacist career, the focus is always on quality...READ MORE

It’s no secret that healthcare is in a state of rapid shifts—it has been for a long time, and it shows no sign of slowing in its evolution—and pharmacy is no exception. From independents to big box to large chains to hospitals, every pharmacist is going to feel (and is already feeling) significant changes...Perhaps the greatest shift in recent years, however, has come from chains. Changes in chains affect not only the pharmacists working in those chains, but show how pharmacy as a whole is evolving...READ MORE

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses techniques to optimize the use of IV robotics in a hospital pharmacy setting. (video)